Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elamipretide in stable heart failure
NCT02388464Phase 1Completed
- Sponsor
- Stealth BioTherapeutics
- Start
- Jul 2014
- Primary completion
- Apr 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of elamipretide in heart failure (HF) (4 arms), sponsored by Stealth BioTherapeutics. Primary endpoint: Incidence of Adverse Events at Day 7. Started Jul 2014; status: completed.
02
Drugs
elamipretide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02388464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02388464.